Recon: US FDA panels return to normal and schedule filling up; Judge rules that J&J must pay Auris investors over $1 billion for violating merger
ReconJason Scott
GlobalMedical DevicesPharmaceuticalsReconJason ScottGlobalMedical DevicesPharmaceuticals